Suppr超能文献

U937细胞中蛋白酶3的生物合成与加工。加工途径与组织蛋白酶G不同。

Biosynthesis and processing of proteinase 3 in U937 cells. Processing pathways are distinct from those of cathepsin G.

作者信息

Rao N V, Rao G V, Marshall B C, Hoidal J R

机构信息

Department of Internal Medicine, Division of Respiratory, Critical Care, and Occupational Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA.

出版信息

J Biol Chem. 1996 Feb 9;271(6):2972-8. doi: 10.1074/jbc.271.6.2972.

Abstract

Proteinase 3 is a human polymorphonuclear leukocyte serine proteinase that degrades elastin in vitro and causes emphysema when administered by intratracheal insufflation into hamsters. Proteinase 3, stored in the azurophilic granules, is expressed in progenitor cells of myeloid origin. In the present study, the biosynthesis, processing, and intracellular transport of the enzyme was investigated in the human myelomonocytic cell line U937. Proteinase 3 is initially identified as a 35-kDa precursor and converted into the 29-kDa mature form within 3 h. By using a combination of techniques including amino-terminal sequencing, we identified the 35-kDa form as a zymogen containing an activation dipeptide but lacking the amino-terminal 25 residues, presumably the result of cleavage by a signal peptidase. Tunicamycin treatment and alkalinization of acidic cell compartments with NH4Cl did not prevent the processing of the proteinase 3 zymogen into the mature form, suggesting that the enzyme is targeted to the cytoplasmic granules by a mechanism other than the mannose 6-phosphate receptor. Brefeldin A inhibited the zymogen processing, suggesting that the dipeptide cleavage occurred in a post-Golgi organelle. The enzyme responsible for the removal of the dipeptide is a cysteine proteinase since E-64d, a class-specific inhibitor, prevented processing. However, treatment of cells with a dipeptidyl peptidase I inhibitor, Gly-Phe-diazomethyl ketone and with the lysosomotropic agents, NH4Cl and chloroquine, did not prevent dipeptide cleavage, indicating that the processing enzyme for proteinase 3 is not dipeptidyl peptidase I. In contrast, Gly-Phe-diazomethyl ketone inhibited cleavage of the dipeptide from cathepsin G. This indicates that processing of proteinase 3 is distinct from that of cathepsin G. Proteinase 3 is also processed at the COOH-terminal extension. Cleavage takes place next to Arg-222, suggesting that a trypsin-like proteinase is involved in the COOH-terminal processing.

摘要

蛋白酶3是一种人类多形核白细胞丝氨酸蛋白酶,它在体外可降解弹性蛋白,通过气管内注入仓鼠可导致肺气肿。蛋白酶3储存于嗜天青颗粒中,在髓系来源的祖细胞中表达。在本研究中,在人骨髓单核细胞系U937中研究了该酶的生物合成、加工及细胞内运输。蛋白酶3最初被鉴定为35 kDa的前体,并在3小时内转化为29 kDa的成熟形式。通过使用包括氨基末端测序在内的多种技术组合,我们将35 kDa的形式鉴定为一种含有激活二肽但缺少氨基末端25个残基的酶原,推测这是信号肽酶切割的结果。衣霉素处理以及用氯化铵对酸性细胞区室进行碱化并不能阻止蛋白酶3酶原加工成成熟形式,这表明该酶通过一种不同于甘露糖6 - 磷酸受体的机制靶向细胞质颗粒。布雷菲德菌素A抑制酶原加工,表明二肽切割发生在高尔基体后细胞器中。负责去除二肽的酶是一种半胱氨酸蛋白酶,因为特异性抑制剂E - 64d可阻止加工。然而,用二肽基肽酶I抑制剂甘氨酰 - 苯丙氨酸 - 重氮甲基酮以及溶酶体促渗剂氯化铵和氯喹处理细胞并不能阻止二肽切割,这表明蛋白酶3的加工酶不是二肽基肽酶I。相反,甘氨酰 - 苯丙氨酸 - 重氮甲基酮抑制组织蛋白酶G中二肽的切割。这表明蛋白酶3的加工与组织蛋白酶G不同。蛋白酶3在COOH末端延伸处也进行加工。切割发生在Arg - 222旁边,表明一种类胰蛋白酶参与了COOH末端的加工。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验